| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to biotechnology, specifically to preparations inhibiting angiogenesis, and may be used in medicine. The method involves administering an EGFL8 antagonist to a subject suffering a pathological condition associated with angiogenesis.EFFECT: invention enables inhibiting the vascular growth in pathological, eg tumour tissues.14 cl, 4 dwg, 2 ex |
